Solace, a fast-growing digital health startup that connects patients with professional health advocates, has closed a $60 million Series B funding round to accelerate its mission to make personalized healthcare advocacy a standard part of care in the U.S. healthcare system.
Founded in 2022, Solace was created to solve a fundamental problem—navigating the healthcare system is often overwhelming and inefficient for patients. By placing human-centered advocacy at the heart of healthcare, Solace is driving better outcomes, reducing overall costs, and vastly improving patient experiences.
Menlo Ventures Leads as Investors Back Advocacy-First Care Model
The latest round was led by Menlo Ventures, with continued support from Craft Ventures, Inspired Capital, and Torch Capital. SignalFire joined as a new investor, signaling growing confidence in Solace’s mission and early traction.
According to Solace CEO and co-founder Jeremy Gurewitz, the health industry is undergoing a critical shift: “We’re at a pivotal moment. Health insurers are realizing that patient advocacy isn’t just a nice-to-have—it’s absolutely essential,” he said. “This raise validates our vision and shows just how central advocacy will be to the future of care.”
Tech-Enabled Advocacy Platform Sets Solace Apart
At the core of Solace’s offering is a proprietary electronic health records (EHR) system and a smart data platform designed to remove friction from the care journey. This tech backbone powers the company’s ability to deliver real-time, personalized support through a national network of health advocates.
“Legacy healthcare systems can’t meet today’s expectations,” said Sara Sargent, Chief Product Officer and co-founder of Solace. “Solace provides tailored, tech-powered guidance at scale. Our platform proactively supports patients, helps them make informed decisions, and embeds advocacy directly into their healthcare experience.”
Growth Signals Demand for Human-Centered Health Navigation
This Series B funding follows a period of rapid momentum for Solace, reflecting growing demand for care solutions that put people—not bureaucracy—at the center. With rising costs and increasingly complex care needs, both payers and patients are seeking better ways to navigate the system.
JP Sanday, Partner at Menlo Ventures, emphasized that this investment is about more than just potential—it’s about results. “Solace has already demonstrated strong clinical and financial outcomes. Their platform doesn’t just improve patient satisfaction; it delivers real value for insurers and providers alike.”
With this fresh capital, Solace plans to expand its advocate network nationwide and enhance the user experience for both patients and care professionals. The funding will also support further development of its platform to scale its proactive, data-driven approach.
Advocacy is Emerging as the Future of Healthcare Delivery
As the healthcare landscape evolves, advocacy is emerging as a cornerstone of modern care. Solace is positioning itself at the forefront of this shift by combining compassionate human support with innovative technology.
By helping people navigate their care journey with clarity and confidence, Solace is redefining what it means to receive care—one patient at a time.
